SPEAC and Brighton Collaboration Featured in Task Force for Global Health’s Spotlight on Mpox Vaccine Safety July 3, 2025
Strengthening Vaccine Safety from Outbreaks to Infants: SPEAC at the World Vaccine Congress May 27, 2025
Updated Landscape Analysis for Priority List of Adverse Events of Special Interest: Chikunguyna April 3, 2025
Validating a proposed case definition for Vaccine-Induced Immune Thrombocytopenia and Thrombosis December 11, 2024
Report of a SPEAC webinar 22 September 2023: Sensorineural hearing loss, Lassa virus disease and vaccines. December 3, 2024
Burden of Lassa fever disease in pregnant women and children and options for prevention November 14, 2024